Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends Professor Olaf Klungel 09/03/2023
Finalised Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines Professor Miriam Sturkenboom 09/01/2023
Finalised ACCESS template protocol for safety of COVID-19 vaccines Professor Miriam Sturkenboom 09/01/2023
Finalised Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination Professor Miriam Sturkenboom 09/01/2023
Finalised Strengthening Use of Real-World Data in Medicines Development: Metadata for Data Discoverability and Study Replicability Dr Susana Perez-Gutthann 18/10/2022
Finalised Characterising the risk of major bleeding in patients with Non-Valvular Atrial Fibrillation: non-interventional study of patients taking Direct Oral Anticoagulants in the EU Dr Helga Gardarsdottir 17/03/2022
Finalised Changes in alternative treatments for pain and cough in children after introduction of risk minimisation measures for codeine Mr Daniel Nogueras Zondag 15/12/2021
Finalised URANIS –Data collection in urological centers during treatment with Ra-223 dichloride (Xofigo) within the framework of a non-interventional study assessing overall survival (OS) and effectiveness predictors of Ra-223 dichloride treated mCRPC patients in a real life setting in Germany Dr Bayer Clinical Trials BAYER AG 29/10/2021
Finalised The risk of acute liver injury associated with the use of antibiotics. A methodological comparison across epidemiological data sources Dr Ana Ruigomez 07/03/2019
Finalised Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children Professor Miriam Sturkenboom 27/11/2017
Ongoing Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources Professor Miriam Sturkenboom 09/01/2023
Ongoing Real-world effectiveness of different COVID-19 vaccines in Spain: a cohort study based on public electronic health records (BIFAP) Dr Elisa Martín-Merino 30/08/2021
Ongoing USE OF DRUGS ACTING ON RENIN-ANGIOTENSIN SYSTEM (RAS) AND RISK OF COVID-19: A CASE-POPULATION STUDY Professor Francisco José de Abajo Iglesias 02/04/2020
Planned Effectiveness of antiresorptives in preventing hip fractures in older women (≥ 75 years) with osteoporosis: nested case-control study cohort Dr Cedeño Veloz Bernardo Abel 20/03/2023
Planned Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen Dr Elisa Martín Merino 22/12/2022
Planned Risk of thromboembolic events and thrombocytopenia after vaccination against COVID-19 Dr Patricia García Poza 27/09/2022
Planned Metamizole and risk of agranulocytosis Dr Elisa Martín-Merino 14/09/2022
Planned TREATMENT WITH BISMUTE SUBCITRATE IN FRAGILE PATIENTS WITH SARS-CoV-2 INFECTION AND DIARRHEA NOT FITTING FOR TRANSFER TO ACUTE HOSPITAL (COVID-19) Dr Eugenia Sopena 28/04/2020
Planned Description of the cutaneous manifestations of Covid-19 Ms Cristina Galvan Casas 02/04/2020
Planned Spanish Registry of treatment efficacy against SARS-CoV-2 COVID-19 Dr Jesus F Sierra Sánchez 29/03/2020
Planned Exposure and coverage to routine schedule vaccines in different EU countries Professor Miriam Sturkenboom 02/02/2019